Bolt Biotherapeutics (BOLT) Appoints Laura Berner to Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Go back to Bolt Biotherapeutics (BOLT) Appoints Laura Berner to Board of Directors
December 14, 2022 4:43 PM EST
REDWOOD CITY, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced the appointment of Laura Berner to its Board of Directors effective Dec. 14, 2022.
Laura is an accomplished biopharmaceutical executive with impressive corporate leadership, operations, and business development experience, said Randall Schatzman, Ph.D., Chief Executive Officer of Bolt Biotherapeutics. As we continue to advance our immuno-oncology pipeline programs in the clinic, Laura brings important strategic perspective from leading and executing more than 50 transactions including research collaborations and... More
